Results 8,821-8,840 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I understand. I realise that everybody is different.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Everybody is different.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is a scale applied?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is there no scale?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is a metric or matrix applied?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Yes.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is that part of the review?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Good. Let us say that the HSE is correct about levels of dependency. Given their personal experience and expertise in this area, do the witnesses think that is credible? I know it is not Mr. Sloyan's role but I am interested in his view.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: When will the review be published?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: I know about the process. When does the review go to the Department?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Do the witnesses think that the Act is fit for purpose?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is it fit for purpose now or does it need to be updated?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: A lot of people do not understand it. Indeed, I have difficulty in understanding it myself at times. I know there is the 80:20 ratio and a call on 7.5% of assets for a maximum of three years. Is that correct?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Let us say a person's house is worth €650,000 and he or she has savings of €80,000 but has a very low income after tax. The person is 75 years old and lives for three years after admission to the fair deal scheme. The person's net worth on death is €730,000. Let us say for argument's sake, that the fair deal scheme needs €230,000 to cover the cost of care. What...
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Where does it go?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: That goes to the estate. Okay.
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: What happens in the case of surviving relatives who have no money but have a house? Are people put out of the house so that it can be sold? What way does that work?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: Is that for a period of time or for their lifetime?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: A life interest?
- Public Accounts Committee: Financial Statements 2016: National Treatment Purchase Fund (14 Jun 2018)
Marc MacSharry: What about a son?